IL22 and asthma: In regard to the overview of the very likely role of IL-17 and IL-22 in airway remodeling in asthma that we provide in this review, this therapeutic perspective is particularly interesting as there is currently no specific pharmacological treatment targeting airway remodeling in asthma, whereas several biotherapies are available for patients with severe T2high asthma.